BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35382744)

  • 1. Investigating treatment-effect modification by a continuous covariate in IPD meta-analysis: an approach using fractional polynomials.
    Sauerbrei W; Royston P
    BMC Med Res Methodol; 2022 Apr; 22(1):98. PubMed ID: 35382744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of continuous effect modifiers in a meta-analysis on higher versus lower PEEP in patients requiring mechanical ventilation--protocol of the ICEM study.
    Kasenda B; Sauerbrei W; Royston P; Briel M
    Syst Rev; 2014 May; 3():46. PubMed ID: 24887172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-STEPP: subpopulation treatment effect pattern plot for individual patient data meta-analysis.
    Wang XV; Cole B; Bonetti M; Gelber RD
    Stat Med; 2016 Sep; 35(21):3704-16. PubMed ID: 27073066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials.
    Royston P; Sauerbrei W
    Stat Med; 2004 Aug; 23(16):2509-25. PubMed ID: 15287081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-STEPP with random effects.
    Wang XV; Cole B; Bonetti M; Gelber RD
    Res Synth Methods; 2018 Jun; 9(2):312-317. PubMed ID: 29281174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Simulation Study Comparing Different Statistical Approaches for the Identification of Predictive Biomarkers.
    Haller B; Ulm K; Hapfelmeier A
    Comput Math Methods Med; 2019; 2019():7037230. PubMed ID: 31312252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes.
    Yip WK; Bonetti M; Cole BF; Barcella W; Wang XV; Lazar A; Gelber RD
    Clin Trials; 2016 Aug; 13(4):382-90. PubMed ID: 27094489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulation-based power calculations for planning a two-stage individual participant data meta-analysis.
    Ensor J; Burke DL; Snell KIE; Hemming K; Riley RD
    BMC Med Res Methodol; 2018 May; 18(1):41. PubMed ID: 29776399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariable fractional polynomial interaction to investigate continuous effect modifiers in a meta-analysis on higher versus lower PEEP for patients with ARDS.
    Kasenda B; Sauerbrei W; Royston P; Mercat A; Slutsky AS; Cook D; Guyatt GH; Brochard L; Richard JC; Stewart TE; Meade M; Briel M
    BMJ Open; 2016 Sep; 6(9):e011148. PubMed ID: 27609843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of treatment with a continuous variable: simulation study of power for several methods of analysis.
    Royston P; Sauerbrei W
    Stat Med; 2014 Nov; 33(27):4695-708. PubMed ID: 25244679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual participant data meta-analyses compared with meta-analyses based on aggregate data.
    Tudur Smith C; Marcucci M; Nolan SJ; Iorio A; Sudell M; Riley R; Rovers MM; Williamson PR
    Cochrane Database Syst Rev; 2016 Sep; 9(9):MR000007. PubMed ID: 27595791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of multiple covariates in assessing treatment-effect modifiers: A methodological review of individual participant data meta-analyses.
    Godolphin PJ; Marlin N; Cornett C; Fisher DJ; Tierney JF; White IR; Rogozińska E
    Res Synth Methods; 2024 Jan; 15(1):107-116. PubMed ID: 37771175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP.
    Lazar AA; Bonetti M; Cole BF; Yip WK; Gelber RD
    Clin Trials; 2016 Apr; 13(2):169-79. PubMed ID: 26493094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: Statistical recommendations for conduct and planning.
    Riley RD; Debray TPA; Fisher D; Hattle M; Marlin N; Hoogland J; Gueyffier F; Staessen JA; Wang J; Moons KGM; Reitsma JB; Ensor J
    Stat Med; 2020 Jul; 39(15):2115-2137. PubMed ID: 32350891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To share or not to share data: how valid are trials evaluating first-line ovulation induction for polycystic ovary syndrome?
    Bordewijk EM; Wang R; van Wely M; Costello MF; Norman RJ; Teede H; Gurrin LC; Mol BW; Li W
    Hum Reprod Update; 2020 Nov; 26(6):929-941. PubMed ID: 32935841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new strategy for meta-analysis of continuous covariates in observational studies.
    Sauerbrei W; Royston P
    Stat Med; 2011 Dec; 30(28):3341-60. PubMed ID: 21953493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculating the power of a planned individual participant data meta-analysis of randomised trials to examine a treatment-covariate interaction with a time-to-event outcome.
    Riley RD; Collins GS; Hattle M; Whittle R; Ensor J
    Res Synth Methods; 2023 Sep; 14(5):718-730. PubMed ID: 37386750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.